These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1145115)

  • 21. The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria.
    van Kamp H; van Imhoff GW; de Wolf JT; Smit JW; Halie MR; Vellenga E
    Br J Haematol; 1995 Jan; 89(1):79-82. PubMed ID: 7833280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of properdin, O degree factor, polyinosinic acid, and thrombin in the haemolysis of paroxysmal nocturnal haemoglobinuria erythrocytes.
    Yachnin S
    Nature; 1965 Jul; 207(996):536. PubMed ID: 5886150
    [No Abstract]   [Full Text] [Related]  

  • 23. Production of paroxysmal nocturnal haemoglobinuria-like red cells by reducing and oxidizing agents.
    Goldstein BD
    Br J Haematol; 1974 Jan; 26(1):49-58. PubMed ID: 4853886
    [No Abstract]   [Full Text] [Related]  

  • 24. Piperacillin-tazobactam drug-induced immune haemolysis in a case of paroxysmal nocturnal haemoglobinuria.
    McDonald L; Brodie R; Murphy K; Wright P; Webster R; Fitzgerald J
    Transfus Med; 2019 Apr; 29(2):138-140. PubMed ID: 30916843
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenal steroids and haemolysis in paroxysmal nocturnal haemoglobinuria.
    Morley AA; Baker LR; Beardwell CG; Burke CW
    Lancet; 1967 Aug; 2(7513):448-50. PubMed ID: 4166109
    [No Abstract]   [Full Text] [Related]  

  • 27. Variations in the red cells in paroxysmal nocturnal haemoglobinuria.
    Rosse WF
    Br J Haematol; 1973 Mar; 24(3):327-42. PubMed ID: 4713634
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro effects of low-molecular weight heparin and dexamethasone on the hemolysis of red blood cells from paroxysmal nocturnal hemoglobinuria patients].
    Zhao M; Shao Z; Liu H; Li K; Cao Z; Tian P; Fu R; Shi J; He G; Bai J; Cui Z; Yang T
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):80-2. PubMed ID: 12015076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sucrose haemolysis: a simple screening test for paroxysmal nocturnal haemoglobinuria.
    Woods WE; O'Neill BJ
    Med J Aust; 1969 Jan; 1(1):21-2. PubMed ID: 5777881
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro studies on the effects of dextrans of various molecular weights on the hemolysis of erythrocytes in nocturnal paroxysmal hemoglobinuria].
    Struzik T; Kowalczyk M; Frendo J
    Pol Tyg Lek; 1969 Jul; 24(27):1061-4. PubMed ID: 5805886
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucocorticoid management of paroxysmal nocturnal haemoglobinuria.
    Firkin F; Goldberg H; Firkin BG
    Australas Ann Med; 1968 May; 17(2):127-34. PubMed ID: 5668172
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between the proportion of paroxysmal nocturnal hemoglobinuria (PNH) III-erythrocytes and the frequency of exacerbated hemoglobinuria in PNH.
    Shichishima T; Terasawa T; Uchida T; Maruyama Y
    Eur J Haematol; 1991 Sep; 47(3):235-6. PubMed ID: 1915809
    [No Abstract]   [Full Text] [Related]  

  • 33. Paroxysmal nocturnal hemoglobinuria "obscured" by the presence of iron deficiency.
    Kann HE; Mengel CE; Wall RL
    Ann Intern Med; 1967 Sep; 67(3):593-6. PubMed ID: 6042648
    [No Abstract]   [Full Text] [Related]  

  • 34. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythopoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria.
    Hill A; Richards SJ; Rother RP; Hillmen P
    Haematologica; 2007 Mar; 92(3):e31-3. PubMed ID: 17405753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro production of PNH-like red blood cells by 2-mercaptopropionylglycine.
    Falezza GC; Corrocher R; Olivieri O; Capra F; Trevisoi E; Pennacchioni A; De Sandre G
    Acta Haematol; 1980; 64(6):310-4. PubMed ID: 6782795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry.
    Almeida AM; Bedrosian C; Cole A; Muus P; Schrezenmeier H; Szer J; Rosse WF
    Intern Med J; 2017 Sep; 47(9):1026-1034. PubMed ID: 28608499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New perspectives on the thrombotic complications of haemolysis.
    L'Acqua C; Hod E
    Br J Haematol; 2015 Jan; 168(2):175-85. PubMed ID: 25307023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.
    Kurita N; Obara N; Fukuda K; Nishikii H; Sato S; Inagawa S; Kurokawa T; Owada Y; Ninomiya H; Chiba S
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):658-62. PubMed ID: 23917586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.